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This Author Correction corrects the following errors in the Article. The authors neglected to cite a relevant study 
related to the isolation of the EGS strain of Toxoplasma gondii from amniotic fluid from a congenitally infected 
Brazilian fetus. As a result, in the Introduction,
“To address these challenges, we characterized the EGS parasite (Fig. 1), isolated in 1994 from amniotic fluid of a 
congenitally infected Brazilian fetus25, that form cyst-like structures in vitro.”
should read:
“To address these challenges, we characterized the EGS parasite (Fig. 1; ATCC® PRA-396), isolated in 1994 from 
amniotic fluid of a congenitally infected Brazilian fetus1 that form cyst-like structures in vitro25.”
In the Results section, under subheading ‘Characterization of EGS strain develops novel in vitro models to test 
compounds’,
“This AP2 represses bradyzoite to tachyzoite conversion, among other differences (Table 1; Fig. 1c; Supplement A: 
Box and Figure S2, Supplement B: Excel Table S1).”
should read:
“This AP2 represses tachyzoite to bradyzoite conversion2, among other differences (Table 1; Fig. 1c; Supplement 
A: Box and Figure S2, Supplement B: Excel Table S1).”
In Figure 6d, the incorrect image for transfected EGS was used. The correct Figure 6d appears below as Figure 1.
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Finally, in the Discussion section,
“This Apetela 2 plant like transcription factor gene is known to drive tachyzoite switch by repressing bradyzoite 
genes.”
should read:
“This Apetela 2, plant-like transcription factor gene, AP2IV-4, represses bradyzoite genes during the tachyzoite 
cell cycle, thereby preventing commitment to the bradyzoite developmental pathway2.”
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